OTC Watch

All stocks / AIBT

AIBOTICS THERAPIES, INC. AIBT

Aibotics Therapies (AIBT): shares outstanding up 343% in a year, a late 10-Q notice in November 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.

Late filingDilutionEstimated float OTCIDFlorida, USA
Live quote on OTC Markets

Market listing

Full name
AIBOTICS INC
Market tier
OTC Pink Current
Trading status
Active
Last trade
Nov 16
Source: Stockwatch, 2026-11-17

News headlines

AIBotics Recaps 2026 Achievements and Outlines Growth Strategy for 2027
2026-11-03 09:15 · News Release
AIBotics Clarifies Recent Increase in Shares Outstanding Following Insider Debt-to-Equity Conversions
2026-10-30 11:31 · News Release
AIBotics Provides PHILL ROBOT(TM) Manufacturing Update as 3DX Industries Supports Five-Unit Pilot
2026-10-28 09:15 · News Release
AIBotics Positions Google Partner NovaCore Labs to Capture Growing Technology Opportunities Across the Caribbean
2026-10-27 11:00 · News Release
CARICOM Technology Company and Google Partner NovaCore Labs Sets Course for Caribbean Expansion Under AIBotics
2026-10-27 09:15 · News Release
AIBotics Advances PHILL ROBOT(TM) Trademark Protection as AI Wellness Platform Moves Toward Commercialization
2026-10-21 09:42 · News Release
Google Partner Novacore Labs and AIBotics Complete Acquisition of Assets, Expanding AI, Drone, Mapping and Automation Platform in Jamaica
2026-10-19 11:00 · News Release
Google Partner Novacore Labs and AIBotics Complete Acquisition of Assets, Expanding AI, Drone, Mapping and Automation Platform in Jamaica
2026-10-16 16:53 · News Release
AIBotics Israeli Partner Ultrobotix Launches Food-Manufacturing Robotics Initiative with Potential for Broader Industrial Deployment
2026-10-15 08:42 · News Release
Ultrobotix Begins Working with a Food Manufacturer to Explore Humanoid Robotic Solutions for Production-Line Tasks
2026-10-15 08:30 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Revenue
$2,183
Net loss
($2,215,751)
What it means

It spends more than it earns

Under strain

Customers paid it $2,183 in the year. It lost $2.2 million. For every $1 that came in, about $1016.00 went out.

The report says
Cash and cash equivalents
$255,940
Net cash used in operating activities
($458,240)
What it means

The cash could run out soon

Under strain

It had $255,940 in the bank and used about $38,187 a month. At that pace the money lasts about 7 months unless it borrows or sells more shares.

The report says
Total assets
$874,673
Total liabilities
$4,834,905
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $874,673. Its debts and unpaid bills add up to $4.8 million. That is about $5.53 owed for every $1 owned.

What this adds up to

3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Late filing2026-11-16

Filed NT 10-Q on 2026-11-16: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Dilution2026-08-19

Shares outstanding rose from 191,904,437 (2025-08-19) to 850,165,334 (2026-08-19), up 343%.

Rule: Shares outstanding up 20% or more in 12 months. Source record

Estimated float2026-08-19

Estimated float about 850,165,334 shares as of 2026-08-19: 850,165,334 outstanding minus 0 held by 0 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Late filing2026-08-14

Filed NT 10-Q on 2026-08-14: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Late filing2026-05-15

Filed NT 10-Q on 2026-05-15: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Late filing2026-03-31

Filed NT 10-K on 2026-03-31: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Shares outstanding

Source: SEC filings
2025-09-30
318.9M
2025-11-19
440.6M
2025-12-31
486.9M
2026-03-31
539.4M
2026-04-15
567.7M
2026-06-08
682.0M
2026-06-30
722.5M
2026-08-19
850.2M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-16 NT 10-QFORM NT 10-Q FILING
2026-10-29 SCHEDULE 13G
2026-10-16 8-KAIBOTICS, INC. - FORM 8-K SEC FILING
2026-10-05 8-KAIBOTICS, INC. - FORM 8-K SEC FILING
2026-08-19 10-QAIBOTICS, INC. - FORM 10-Q SEC FILING
2026-08-14 NT 10-QFORM NT 10-Q FILING
2026-06-09 10-QAIBOTICS, INC. - FORM 10-Q SEC FILING
2026-05-15 NT 10-QFORM NT 10-Q FILING
2026-04-15 10-KAIBOTICS, INC. - FORM 10-K SEC FILING
2026-03-31 NT 10-KAIBOTICS, INC.- NT10K
2026-01-28 S-8AIBOTICS INC. - FORM S-8 FILING
2025-11-19 10-QAIBOTICS, INC. - FORM 10-Q SEC FILING

Common questions about AIBT

Does AIBT file reports with the SEC?

Yes. Aibotics Therapies files with the SEC under company number 0001763329. The most recent filing we hold is a NT 10-Q dated 2026-11-16.

Source record

How many AIBT shares are outstanding?

850,165,334 shares as of 2026-08-19, as reported to the SEC. That is up 343% from 191,904,437 on 2025-08-19.

Source record

Has AIBT filed reports late?

Yes. In the last 12 months it filed 4 late-filing notices, most recently a NT 10-Q on 2026-11-16. A notice means a report was not ready on time; check whether the report followed.

Source record

Is Aibotics Therapies making money?

Customers paid it $2,183 in the year. It lost $2.2 million. For every $1 that came in, about $1016.00 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record